# Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects

> **NCT02040311** · PHASE4 · TERMINATED · sponsor: **University of Copenhagen** · enrollment: 701 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Topiramate 96 mg daily
- **DRUG:** Topiramate 192 mg daily
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02040311
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-08
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** 701 (ACTUAL)
- **Why stopped:** Study was terminated early as sponsor wanted to develop an improved formulation.
- **Last updated:** 2014-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040311, "Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02040311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*